Stay updated on Galcanezumab for Vestibular Migraine Clinical Trial
Sign up to get notified when there's something new on the Galcanezumab for Vestibular Migraine Clinical Trial page.

Latest updates to the Galcanezumab for Vestibular Migraine Clinical Trial page
- Check2 days agoChange DetectedThe update changes the displayed ClinicalTrials.gov interface revision version from v3.5.2 to v3.5.3, reflecting a minor site release rather than any modification to the trial record itself.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to study data or page content.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedA new revision v3.5.0 is added to the record history, and revision v3.4.3 is removed.SummaryDifference0.1%

- Check45 days agoChange DetectedNew revision tag v3.4.3 was added to the page history and the previous tag v3.4.2 was removed.SummaryDifference0.1%

- Check73 days agoChange DetectedA new revision entry (v3.4.2) was added to the study history. The deletions include a site-wide funding notice and the previous revision (v3.4.1).SummaryDifference0.8%

- Check80 days agoChange DetectedA government funding notice banner and a revision label to v3.4.1 were added, and the prior revision label v3.4.0 was removed.SummaryDifference0.8%

Stay in the know with updates to Galcanezumab for Vestibular Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galcanezumab for Vestibular Migraine Clinical Trial page.